tiprankstipranks
Advertisement
Advertisement

NVCR Stock Latest News

NovoCure’s PANOVA-4 Trial Hits Completion, Raising New Questions for Pancreatic Cancer Investors
Company AnnouncementsNovoCure’s PANOVA-4 Trial Hits Completion, Raising New Questions for Pancreatic Cancer Investors
3d ago
NVCR
Novocure aware of unauthorized access to some information systems
PremiumThe Fly
Novocure aware of unauthorized access to some information systems
6d ago
NVCR
Novocure price target raised to $20 from $18 at Wedbush
PremiumThe Fly
Novocure price target raised to $20 from $18 at Wedbush
2M ago
NVCR
NovoCure Earnings Call Highlights Growth With Caution
PremiumCompany Announcements
NovoCure Earnings Call Highlights Growth With Caution
2M ago
NVCR
Novocure price target raised to $52 from $46 at H.C. Wainwright
PremiumThe Fly
Novocure price target raised to $52 from $46 at H.C. Wainwright
2M ago
NVCR
Midday Fly By: Alphabet boosts spending, IBM reports downbeat Q2
PremiumThe FlyMidday Fly By: Alphabet boosts spending, IBM reports downbeat Q2
2M ago
T
AAL
Novocure raises FY26 revenue view to $710M-$725M from $690M-$710M
Premium
The Fly
Novocure raises FY26 revenue view to $710M-$725M from $690M-$710M
2M ago
NVCR
Novocure reports Q2 EPS (13c), consensus (33c)
Premium
The Fly
Novocure reports Q2 EPS (13c), consensus (33c)
2M ago
NVCR
NVCR Earnings this Week: How Will it Perform?
PremiumPre-Earnings
NVCR Earnings this Week: How Will it Perform?
2M ago
NVCR
Novocure resumed with a Neutral at JPMorgan
PremiumThe Fly
Novocure resumed with a Neutral at JPMorgan
2M ago
NVCR
Novocure’s Optune Pax Secures CE Mark for Pancreatic Cancer
PremiumCompany Announcements
Novocure’s Optune Pax Secures CE Mark for Pancreatic Cancer
2M ago
8K
NVCR
Novocure announces Optune Pax received CE Mark
PremiumThe Fly
Novocure announces Optune Pax received CE Mark
2M ago
NVCR
Midday Fly By: Trump says Apple working with Intel to design chips
PremiumThe FlyMidday Fly By: Trump says Apple working with Intel to design chips
3M ago
KR
ACN
Novocure falls -17.0%
Premium
The Fly
Novocure falls -17.0%
3M ago
NVCR
Analyst Maintains Buy on NovoCure, Trims Price Target to $46 Amid Shift to New Indications and Stable GBM Franchise
Premium
Ratings
Analyst Maintains Buy on NovoCure, Trims Price Target to $46 Amid Shift to New Indications and Stable GBM Franchise
3M ago
NVCR
Novocure price target lowered to $46 from $48 at H.C. Wainwright
PremiumThe Fly
Novocure price target lowered to $46 from $48 at H.C. Wainwright
3M ago
NVCR
Novocure falls -18.2%
PremiumThe Fly
Novocure falls -18.2%
3M ago
NVCR
NovoCure Reports Phase 3 TRIDENT Trial Topline Results
PremiumCompany Announcements
NovoCure Reports Phase 3 TRIDENT Trial Topline Results
3M ago
8K
NVCR
Novocure says Phase 3 TRIDENT trial did not meet primary endpoint
PremiumThe Fly
Novocure says Phase 3 TRIDENT trial did not meet primary endpoint
3M ago
NVCR
NovoCure Shareholders Approve Directors, Auditor and Incentive Plan
PremiumCompany AnnouncementsNovoCure Shareholders Approve Directors, Auditor and Incentive Plan
3M ago
8K
NVCR
NovoCure Earnings Call Highlights Growth, One-Time Hit
Premium
Company Announcements
NovoCure Earnings Call Highlights Growth, One-Time Hit
4M ago
NVCR
Novocure price target raised to $17 from $13.50 at Wells Fargo
Premium
The Fly
Novocure price target raised to $17 from $13.50 at Wells Fargo
4M ago
NVCR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >